Carles Domènech, Executive Chairman, Chief Scientific Officer and Co-Founder of AbilityPharma, said: "We are very happy to have reached this agreement with SciClone. This investment represents a cont...
Read moreConnecta Therapeutics has closed a €1.7 million round of investment led by Inveready that will allow the company to take its first drug through to phase IIa clinical trials in patients who have frag...
Read moreConnecta Therapeutics has closed a €1.7 million round of investment led by Inveready that will allow the company to take its first drug through to phase IIa clinical trials in patients who have frag...
Read moreSOM Biotechhas been granted €340,000.00 from the Center for Industrial Technological Development (CDTI, Spain), within the extraordinary call for grants for R&D projects to face the COVID-19 h...
Read moreThe biotech company Oxolife, created to develop a new treatment to improve the female fertility rate, completed its first funding round by raising 5,000,000 euros in an investment led by Inveready Ass...
Read moreThe company announced the initiation a of a drug discovery program towards the identification of novel oral drugs specifically designed to treat infections caused by Corona viruses.
Read moreAccure Therapeutics, a new pharma R&D player in the Central Nervous System (CNS) field, announces today its launch with a Series A round of funding totalling €7.6 million ($8.1M). The funding round ...
Read moreCaixa Innvierte Start is the eighth venture capital fund driven by the ”la Caixa” venture capital firm. With this new vehicle, Caixa Capital Risc now manages an investment volume of 180 million Eu...
Read moreEl objetivo de esta investigación será el diseño de alimentos y test de screening, que permitan reducir el riesgo de algunas de las enfermedades crónicas más frecuentes, que serán causantes de 3...
Read moreLa Caixa is leading this operation through the Caixa Innvierte BioMed II fund, joined by the Sanfilippo Foundation Switzerland
Read more